Cyrus Biotechnology

@cyrusbiotech

Accelerating BioPharma with powerful Rosetta-based protein engineering and modeling software and partnerships. For BioPharma, Synbio, Chem, Consumer, Academia.

Seattle, WA
Vrijeme pridruživanja: srpanj 2015.

Tweetovi

Blokirali ste korisnika/cu @cyrusbiotech

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @cyrusbiotech

  1. proslijedio/la je Tweet

    Deep that outputs relative distances & orientations of all residue pairs in a aids in predicting protein structures — especially for proteins that have been designed (rather than evolved).

    Poništi
  2. 8. sij

    Excited to see ML protein design algorithms from one of the masters of de novo Rosetta design Possu Huang

    Poništi
  3. 7. sij

    We're looking forward to next week! Please reach out info@cyrusbio.com if you'd like to meet to discuss your biologics design needs -- we've solved hard problems in biologics discovery now with 13 of the top 20 Pharma firms

    Poništi
  4. proslijedio/la je Tweet
    13. pro 2019.

    I met Cyrus Chothia once when I was an assistant professor. I remember him being kind and encouraging. Our antibody engineering algorithms rest on his observations.

    Poništi
  5. 13. pro 2019.

    He defined the Universe of protein structures, the boundaries of our microscopic protein world. (And another Cyrus biochemist, though our namesake is Levinthal)

    Poništi
  6. proslijedio/la je Tweet

    ICYMI: Seattle-based and the are collaborating to optimize for use in therapeutic development, focusing on mitigating immune responses to minimize side effects.

    Poništi
  7. 5. pro 2019.

    A very clear layperson's summary of our new CRISPR project in thanks to for the story

    Poništi
  8. 4. pro 2019.

    Very good background on T cell mediated cas immunity in this article

    Poništi
  9. 3. pro 2019.
    Poništi
  10. 3. pro 2019.

    Great, carefully researched article about our new CRISPR project in , carefully puts the work into larger perspective in the field.

    Poništi
  11. 2. pro 2019.

    Looking forward to exciting new science in this collaboration, thanks !

    Poništi
  12. proslijedio/la je Tweet
    2. pro 2019.

    Together, researchers from and will work together to mitigate the possibility of the body mounting an immune response against .

    Poništi
  13. 2. pro 2019.

    Thanks for the mention and for the cool graphic that summarizes this project pretty much in one image, a picture is worth 10,000 lines of code?

    Poništi
  14. 2. pro 2019.

    Announcing a new Cyrus collaboration with the Broad Institute to optimize CRISPR for therapeutic use using Rosetta and computational protein design.

    Poništi
  15. proslijedio/la je Tweet

    Thrilled to be partnering with and Stanley Riddell to help develop CAR T-cell immunotherapies for metastatic breast cancer. The team, powered by a Research Program Breakthrough award, includes , &

    Poništi
  16. proslijedio/la je Tweet
    25. lis 2019.

    Wishing a very happy birthday to Professor Emeritus, Earl Davie! Dr. Davie was among the first to describe how blood clots. He was born in Tacoma, received his undergraduate degree & PhD from , & co founded ZymoGenetics.

    Poništi
  17. 4. lis 2019.
    Poništi
  18. 3. lis 2019.

    Congrats Icosavax! Bringing another beautiful Rosetta designed biologics into the clinic!

    Poništi
  19. 23. ruj 2019.

    Excited to be at our first Symposium today, with our talk on automation in peptide design tomorrow Sept. 24!

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·